You are here
Takeda hikes outlook on cancer drug sales, Q3 profit jumps 60%
TAKEDA Pharmaceutical Co Ltd said that its annual profit will outstrip a prior estimate and reach a six-year high, boosted by stronger sales of the cancer drug Velcade, after earlier reporting better-than-expected quarterly earnings.
Velcade is used to treat multiple myeloma
- CALL +65 6388 3838
- EMAIL email@example.com